top of page

Can Fenbendazole Damage Your Liver or Kidneys?

Oct 23
12 min read

Written by Dr. Charles Drew, Lead Pharmaceutical Content Specialist & Clinical Drug Information Reviewer

Reviewed for medical accuracy under the Ivermectinkart Editorial Policy


Introduction

Fenbendazole is a medicine used to treat parasitic worms in animals, but some people have started taking it after encountering online claims about its possible benefits for cancer. If you're wondering whether fenbendazole can damage your liver or kidneys, the available research points to a clearer risk for the liver than for the kidneys. Published medical reports have documented serious liver injury in people who took fenbendazole without medical supervision. Animal studies have also raised concerns about kidney toxicity, although reliable evidence of direct kidney damage in humans remains limited.


Because fenbendazole is not approved for human use, its safety and appropriate dosage in people have not been established. Understanding what the research actually shows can help you recognize potential warning signs, avoid unnecessary risks, and make informed decisions about your health.


Can Fenbendazole Damage Your Liver or Kidneys? | Ivermectinkart


What Is Fenbendazole, and Why Are Some People Taking It?

Fenbendazole is a veterinary antiparasitic medicine primarily used to treat intestinal worm infections in animals, including dogs, horses, and livestock. It belongs to a group of medicines called benzimidazoles, which interfere with essential processes inside parasitic worms. Although related medicines are used to treat certain human parasitic infections, fenbendazole itself is not approved for treating people.


How Does Fenbendazole Work?

Fenbendazole disrupts structures inside parasitic worms called microtubules.


These tiny structures help cells maintain their shape, move materials, and carry out essential functions.

By interfering with microtubules, fenbendazole prevents susceptible parasites from functioning normally, eventually leading to their death.


This explains why the medicine is useful against particular worms in animals.


However, a medicine that is effective and considered acceptably safe for a specific animal species is not automatically safe for humans.


Different species may absorb, process, and eliminate medicines differently.


Why Has Fenbendazole Become Popular as an Alternative Cancer Treatment?

Fenbendazole has attracted attention because some laboratory and animal studies have investigated whether it can interfere with cancer-related cellular processes.


These early findings have encouraged online discussions about using the veterinary medicine as an alternative cancer treatment.


However, laboratory findings cannot establish that a substance safely treats cancer in people.

There is currently no reliable clinical evidence demonstrating that fenbendazole is an effective human cancer treatment.


The American Cancer Society's explanation of fenbendazole and cancer emphasizes that fenbendazole has not received approval from the US Food and Drug Administration (FDA) for any human use and that its safety and effectiveness in people remain unestablished.


This distinction is especially important for people receiving cancer treatment.


Taking an unapproved substance alongside prescribed medicines may complicate treatment decisions, particularly if liver problems develop.


Can Fenbendazole Cause Liver Damage?

Yes. Fenbendazole has been associated with medically documented cases of liver injury in humans, including serious cases requiring hospital care. Although researchers do not yet know how frequently this happens, the available evidence is strong enough to consider liver damage a genuine safety concern rather than a purely theoretical possibility.


How Might Fenbendazole Affect the Liver?

Your liver helps process medicines and other substances that enter your bloodstream.


During this process, certain medicines or their breakdown products can sometimes injure liver cells.

This is known as drug-induced liver injury, often shortened to DILI.


Fenbendazole has been associated with this type of injury in people who took it for unapproved purposes.

The exact mechanism is not fully understood. Some cases may involve an unpredictable reaction to the medicine rather than toxicity that increases in a simple, predictable way with the amount taken.


According to the NIH LiverTox review of fenbendazole-related liver injury, published in April 2026, reported cases have ranged from relatively mild liver abnormalities to severe and potentially life-threatening liver injury.


An important concern is that early liver injury may not produce obvious symptoms.


Someone may feel reasonably well even when blood tests show that liver cells are being damaged.


What Have Human Case Reports Found?

One particularly important report appeared in ACG Case Reports Journal in May 2024.


The researchers described a 67-year-old woman who developed severe liver injury after taking veterinary fenbendazole herself.


She experienced jaundice, a condition that causes yellowing of the skin or eyes when bilirubin, a yellow substance normally processed by the liver, builds up in the body.


A liver biopsy, which examines a small sample of liver tissue, revealed substantial injury to liver cells.


After fenbendazole was discontinued and she received medical care, her liver blood tests gradually improved and returned to normal within three months.



A separate case report published in January 2026 described a 47-year-old woman with metastatic colon cancer who developed severe liver injury after increasing her self-administered fenbendazole use while receiving immunotherapy.


Researchers considered fenbendazole the probable cause following a structured assessment, and her liver tests improved after she stopped taking it.


These reports are important, but they also have limitations.


A case report describes what happened to an individual patient. It can identify a serious safety signal, especially when symptoms and test results improve after stopping a substance, but it cannot establish how frequently the same reaction occurs in the wider population.


Does Liver Damage Always Happen After Long-Term Use?

No. Available reports do not establish a predictable period of use after which liver damage begins.

The April 2026 LiverTox review describes liver injury developing after periods ranging from days to many months.


This means that neither short-term use nor a smaller amount can be assumed safe.


It also means that someone who previously took fenbendazole without apparent problems should not assume that future use carries no risk.


Can Fenbendazole Damage Your Kidneys?

Fenbendazole has produced signs of kidney damage in animal experiments, but there is not enough reliable human evidence to establish whether it directly causes kidney injury in people. The possibility deserves attention, particularly because human kidney safety has not been adequately studied.


However, animal findings should not be presented as proof of human kidney toxicity.


What Have Animal Studies Found?

A 1992 study published in Veterinary and Human Toxicology examined the effects of fenbendazole given to rats for 14 consecutive days.


At high experimental doses, researchers observed changes in kidney tissues, along with increased blood creatinine.


Creatinine is a waste product measured in blood tests to help assess how well the kidneys are filtering waste.


The researchers also identified changes in liver cells.


These observations are described in the 1992 study of fenbendazole toxicity in rats .


However, the study involved animals receiving high experimental doses.


It does not tell us whether comparable kidney effects occur in humans, what level of exposure might produce them, or how frequently they might develop.


Why Is Human Kidney Safety Still Uncertain?

Your kidneys filter waste from the blood and help regulate fluid and mineral balance.


Some medicines can interfere with these functions, but establishing that a particular medicine causes kidney injury requires appropriate evidence.


For fenbendazole, the human safety literature is concentrated mainly on liver-related case reports.


There are not enough well-designed human studies to establish a reliable kidney risk estimate.


This creates two important distinctions:


  • There is evidence of possible kidney toxicity in animals.

  • There is insufficient evidence to confirm a direct kidney injury risk in humans.


A lack of confirmed human cases does not demonstrate that the medicine is harmless to the kidneys.


Because fenbendazole is not an approved human treatment, there is no established human dosage that can be relied upon to protect kidney function.


What current research shows about possible fenbendazole damage to the liver and kidneys.

Area examined

What research has found

What this means for people

Liver injury in humans

Published case reports describe liver inflammation and severe liver-cell injury associated with fenbendazole.

A credible human safety risk has been identified.

Liver recovery in humans

Some reported patients improved after stopping fenbendazole and receiving medical care.

Recovery is possible, but it cannot be guaranteed.

Kidney injury in humans

Reliable evidence is insufficient to establish a direct causal relationship or estimate risk.

Kidney safety remains uncertain, not proven.

Kidney injury in animals

High-dose rat experiments documented kidney tissue changes and increased creatinine.

Animal findings raise concern but cannot establish human risk.

Long-term human exposure

Adequate studies of long-term liver and kidney safety are lacking.

No long-term human-use regimen can be considered established as safe.

Are Some People More Vulnerable to Fenbendazole-Related Side Effects?

Certain health conditions and treatment circumstances may make the consequences of possible drug-related liver or kidney injury particularly concerning. However, researchers have not established which people are most likely to develop fenbendazole toxicity or whether specific doses, schedules, or combinations are safer.


People With Existing Liver or Kidney Disease

If you already have liver disease, your body may have less capacity to cope with additional liver injury.

Conditions such as cirrhosis, chronic hepatitis, or significant existing liver damage can complicate the evaluation and management of drug-related problems.


Similarly, people with reduced kidney function may be more vulnerable to complications if their kidneys become injured for any reason.


This does not mean researchers have confirmed that fenbendazole causes more harm in these groups.


The concern is that its safety has not been adequately studied, making unpredictable reactions especially important to avoid.


People Receiving Cancer Treatment

People undergoing chemotherapy, immunotherapy, or other cancer treatments should be particularly careful about unapproved medicines.


Some cancer treatments can themselves affect liver function.


If someone develops abnormal liver tests while taking fenbendazole alongside prescribed treatment, identifying the cause may become difficult.


For example, inflammation associated with immunotherapy can sometimes resemble drug-induced liver injury.


A healthcare professional may need to investigate several possible explanations before deciding whether a treatment should change.


Fenbendazole should not replace proven cancer treatments, and anyone who has used it should tell their oncology team.


Does Taking Fenbendazole With Other Medicines Increase the Risk?

Potential interactions between fenbendazole and human medicines have not been adequately characterized.


This uncertainty is important because some prescription medicines, nonprescription pain relievers, herbal products, and supplements can independently affect the liver or kidneys.


Taking several substances together can make it harder to determine which one caused an adverse reaction.


However, it would be inaccurate to claim that every combination necessarily increases fenbendazole toxicity.


A clinician should review the complete list of medicines and supplements rather than assume a combination is safe.


How Can Doctors Check for Fenbendazole-Related Liver or Kidney Damage?

Doctors can assess possible organ injury through a combination of medical history, physical examination, and laboratory tests. Blood tests may identify liver-cell damage or reduced kidney function even before obvious symptoms appear. However, no routine blood test can prove by itself that fenbendazole caused an abnormal result.


Blood Tests Used to Check Liver Health

A healthcare professional may recommend a liver blood test panel if someone has taken fenbendazole.

Common measurements include:


  • ALT (alanine aminotransferase): An enzyme that may increase when liver cells are damaged.

  • AST (aspartate aminotransferase): Another enzyme that can rise with liver injury, although it is also found in other tissues.

  • ALP (alkaline phosphatase): An enzyme that can help identify certain liver or bile-duct problems.

  • Bilirubin: A substance that can build up when the liver cannot process or remove it normally.

  • Albumin: A protein made by the liver that helps assess aspects of liver function.

  • INR (international normalized ratio): A measure of how quickly blood clots, which can help assess the severity of certain liver problems.


As explained by the US National Library of Medicine, abnormal liver tests may indicate several different medical conditions and must be interpreted together with symptoms and medical history.


A mildly elevated enzyme result does not automatically mean someone has severe liver disease.


Equally, a person with substantial liver injury may not initially experience dramatic symptoms.


Blood and Urine Tests Used to Check Kidney Health

If kidney problems are suspected, a healthcare professional may recommend several investigations.


Serum creatinine: This blood test measures a waste product normally removed by the kidneys. Higher levels can indicate reduced kidney filtration, although results also depend on other factors.


Estimated glomerular filtration rate (eGFR): This is a calculation that estimates how effectively the kidneys filter blood.


Blood urea: This measures another waste substance. It can provide useful information when considered alongside creatinine and other findings.


Urine testing: A urine sample may be checked for protein, blood, or other abnormalities that could suggest a kidney problem.


These investigations can help identify kidney dysfunction, but they cannot independently establish fenbendazole as the cause.


What Happens If Test Results Are Abnormal?

If liver or kidney tests are abnormal, a doctor will consider other possible causes.


For liver abnormalities, these might include viral hepatitis, other medication reactions, bile-duct problems, or existing liver disease.


For kidney abnormalities, possible explanations include dehydration, infection, urinary blockage, or other medicines.


The timing of fenbendazole exposure is important, but it is only one part of the assessment.


Doctors may repeat laboratory tests to see whether results improve after the suspected substance is discontinued.


In some cases, additional investigations or specialist care may be necessary.


What Should You Do If You Have Already Taken Fenbendazole?

If you have taken fenbendazole for a human health condition, the safest approach is to discontinue unsupervised use and contact a qualified healthcare professional for advice. Even if you feel well, a clinician can review your exposure, medical history, and other medicines to decide whether laboratory testing or follow-up is appropriate.


Tell Your Doctor Exactly What You Have Taken

Provide as much information as possible about the product.


Useful details include:


  • The product name and formulation.

  • The amount you believe you took.

  • How frequently you took it.

  • When you first started and last used it.

  • Any other medicines or supplements taken at the same time.

  • Any new symptoms that developed.


If possible, bring the original packaging or a clear photograph of its label.

This can help your healthcare professional identify the substance and investigate possible adverse effects.


Do Not Try to Prevent Toxicity With Unproven Supplements

Some online discussions recommend taking additional products marketed for liver protection alongside fenbendazole.


However, there is no established human evidence showing that such combinations prevent fenbendazole-induced liver injury.


A case report published in 2026 described liver injury associated with fenbendazole use alongside tauroursodeoxycholic acid (TUDCA), a substance sometimes promoted for liver support. Because both products were used, the report cannot establish the contribution of each one.


Taking a supplement believed to support liver health is not a substitute for avoiding an unapproved drug or obtaining appropriate medical care.


Can the Liver Recover After Fenbendazole Is Stopped?

Recovery is possible, and several reported patients experienced improvement after fenbendazole was discontinued.


However, recovery time and severity may differ considerably.


The fact that some patients recovered does not mean every episode of liver injury will resolve without complications.


If a healthcare professional suspects fenbendazole-induced liver injury, they may recommend repeat tests and follow-up until the problem has resolved.


Reusing fenbendazole after a suspected liver reaction should be avoided.


The strongest human safety signal for fenbendazole is liver injury, while its potential to damage human kidneys remains insufficiently studied. Normal symptoms, reassuring online stories, or the ability to buy a veterinary product without a prescription do not establish that it is safe for human use.

When Should You Seek Urgent Medical Care?

Possible liver or kidney injury can sometimes develop without noticeable symptoms.


However, certain changes should prompt medical attention, especially in someone who has taken an unapproved medicine such as fenbendazole.


Warning Signs of Liver Problems

Important symptoms include:


  • Yellowing of the eyes or skin.

  • Unusually dark urine.

  • Pale or clay-coloured stools.

  • Persistent nausea or vomiting.

  • Loss of appetite and unusual fatigue.

  • Significant itching without an obvious explanation.

  • Pain or discomfort in the upper right abdomen.


These symptoms can have several causes and do not automatically establish fenbendazole-related liver injury.


Nevertheless, new jaundice or other concerning liver symptoms require prompt medical evaluation.


Warning Signs of Kidney Problems

Possible signs of kidney dysfunction include:


  • Passing substantially less urine than usual.

  • New swelling around the ankles, feet, or legs.

  • Unexplained nausea or vomiting.

  • Unusual weakness or pronounced fatigue.

  • Shortness of breath.

  • Confusion or increasing drowsiness.


These are general warning signs of possible kidney problems, not symptoms specifically proven to occur from fenbendazole.


The UK's National Health Service notes that acute kidney injury may produce few or no symptoms initially, making blood testing important when kidney dysfunction is suspected.


Warning signs after fenbendazole exposure and when to seek medical attention.

Situation

Possible signs

Recommended action

Exposure without noticeable symptoms

Fenbendazole taken, but no obvious physical changes

Discontinue unsupervised use and contact a healthcare professional to discuss whether testing is needed.

Symptoms requiring prompt assessment

Persistent nausea, unusual fatigue, itching, abdominal discomfort, or swelling

Seek timely medical assessment; the cause may require blood or urine testing.

Possible significant liver injury

Yellow eyes or skin, dark urine, or pale stools

Seek urgent same-day medical evaluation.

Possible significant kidney injury

Markedly reduced urination, substantial swelling, or persistent vomiting

Seek urgent medical care.

Potential medical emergency

Confusion, fainting, severe abdominal pain, difficulty breathing, or rapidly worsening illness

Go to an emergency department immediately.


The urgency depends on the complete clinical situation, and severe symptoms should never be managed through home remedies alone.


Conclusion

Yes, fenbendazole has been associated with liver damage in humans, including serious cases requiring hospital treatment. Its effects on human kidneys are less certain: high-dose animal studies have identified kidney injury, but adequate human research is lacking. Fenbendazole is not approved for human use in the United States, and no established safe human dosing schedule exists. While some reported patients recovered after stopping the medicine, that does not guarantee safety or recovery for everyone.


If you have taken fenbendazole, discontinue unsupervised use and speak with a qualified healthcare professional about appropriate liver and kidney testing. Seek urgent care for concerning symptoms.


Fenbendazole is an effective and safe dewormer for dogs and cats | Ivermectinkart

Frequently Asked Questions

1 . Can fenbendazole cause liver damage after only a few doses?

Liver injury has been reported after different periods of fenbendazole use, including relatively short exposures. However, the risk associated with any particular number of doses is unknown. If you have taken fenbendazole, discuss your exposure and any symptoms with a healthcare professional.

Some published cases describe liver function returning to normal after fenbendazole was discontinued and patients received medical care. However, recovery is not guaranteed, particularly with severe injury. Follow-up testing is important when drug-induced liver injury is suspected.

There is insufficient reliable human evidence to establish that fenbendazole directly causes kidney failure. High-dose animal experiments have shown kidney injury, but these findings cannot establish human risk. The absence of adequate human studies means kidney safety remains uncertain.

A healthcare professional may consider liver tests such as ALT, AST, bilirubin, and INR, along with kidney tests such as creatinine and eGFR. The appropriate tests depend on your symptoms and medical history. These results cannot prove fenbendazole caused an abnormality.

Fenbendazole has not been established as safe for use alongside chemotherapy or other cancer treatments. Potential interactions and overlapping organ-related side effects are not adequately understood. Tell your oncologist about any fenbendazole exposure and do not replace prescribed cancer treatment with it.

 No reliable human evidence shows that liver-support supplements can prevent fenbendazole-related liver injury. Some supplements may also produce adverse effects or complicate treatment. The safest approach is to avoid unsupervised fenbendazole use rather than rely on additional products for protection.


Comments


bottom of page